Anti-CD4 monoclonal antibody/tumour necrosis factor α inhibitors: Cytokine release syndromes, allergy, CD4+ T-cell lymphopenia and maculopapular rash: 8 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1199, 2008-01, pp. : 6-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous CD4+ T-cell infusion induces regression of tumour

By  

Inpharma, Vol. 1, Iss. 1644, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor-α inhibitors/immunosuppressants: Cancer: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 48-48

Adis International

Access to resources Recommend Favorite

Alefacept/methotrexate: Persistent CD4+ T-cell depression: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Drug-Induced Lymphopenia: Focus on CD4+ and CD8+ Cells

By Gergely P.  

Drug Safety, Vol. 21, Iss. 2, 1999-08 ,pp. : 91-100

Adis International

Access to resources Recommend Favorite

CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 4, 2006-12 ,pp. : 239-242

Bentham Science Publishers

Access to resources Recommend Favorite